Loading clinical trials...
Loading clinical trials...
This long-term follow-up study is being conducted to collect long-term (up to 15 years post-infusion) safety and tolerability data from subjects enrolled in studies evaluating TX200-TR101.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sangamo Therapeutics
NCT07412470 · Kidney Transplant Rejection
NCT07157397 · End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD), and more
NCT06326905 · Quality of Life, Depression, and more
NCT07020832 · Delayed Graft Function, End Stage Renal Disease, and more
NCT07415876 · Kidney Transplant Rejection
University Hospitals Leuven
Leuven
University Medical Center Groningen
Groningen
Leiden University Medical Centre
Leiden
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions